Corbus Pharmaceuticals Holdings, Inc. (CRBP) total assets
Corbus Pharmaceuticals Holdings, Inc. (CRBP) had total assets of $168.20M at the end of fiscal 2025 (December 31, 2025). That is 7.9% higher than the $155.88M of fiscal 2024. Figures as of 18 Nov 2026, 12:38 UTC, from the company's filings with the SEC and Yahoo Finance.
Key facts
- Total assets, fiscal 2025
- $168.20M
- Change on fiscal 2024
- +7.9%
- Growth, 5 years
- +10.5% a year
- Growth, 10 years
- +29.3% a year
- Highest on record
- $168.20Mfiscal 2025
- Lowest on record
- $305.52Kfiscal 2013
- Fiscal years on record
- 132013–2025
Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.
Corbus Pharmaceuticals Holdings, Inc. total assets, in more detail
Over the five fiscal years to 2025 total assets grew at a compound 10.5% a year; over ten years the rate was 29.3% a year. Across the 13 fiscal years on record (2013–2025), the highest was $168.20M in fiscal 2025 and the lowest $305.52K in fiscal 2013.
Total assets by fiscal year
Corbus Pharmaceuticals Holdings, Inc. total assets, year by year
| Fiscal year | Total assets | Change | Year ended |
|---|---|---|---|
| 2025 | $168.20M | 7.9% up | |
| 2024 | $155.88M | 451.4% up | |
| 2023 | $28.27M | 57.4% down | |
| 2022 | $66.31M | 38.4% down | |
| 2021 | $107.73M | 5.3% up | |
| 2020 | $102.29M | 108.2% up | |
| 2019 | $49.14M | 4.6% up | |
| 2018 | $46.99M | 29.8% down | |
| 2017 | $66.98M | 274.4% up | |
| 2016 | $17.89M | 38.9% up | |
| 2015 | $12.88M | 95.1% up | |
| 2014 | $6.60M | 2,060.5% up | |
| 2013 | $305.52K | — |
Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.
How it is calculated
Total assets is everything on the balance sheet at the fiscal year-end — cash, receivables, inventory, property, goodwill and the rest.
How to read it
It measures the resources the business has put to work; assets that grow faster than profit mean each new unit of investment is earning less.
Corbus Pharmaceuticals Holdings, Inc., figure by figure
- Corbus Pharmaceuticals Holdings, Inc. market cap
- Corbus Pharmaceuticals Holdings, Inc. revenue
- Corbus Pharmaceuticals Holdings, Inc. earnings
- Corbus Pharmaceuticals Holdings, Inc. earnings per share (EPS)
- Corbus Pharmaceuticals Holdings, Inc. P/E ratio
- Corbus Pharmaceuticals Holdings, Inc. P/S ratio
- Corbus Pharmaceuticals Holdings, Inc. P/B ratio
- Corbus Pharmaceuticals Holdings, Inc. free cash flow
- Corbus Pharmaceuticals Holdings, Inc. operating margin
- Corbus Pharmaceuticals Holdings, Inc. dividend
- Corbus Pharmaceuticals Holdings, Inc. shares outstanding
- Corbus Pharmaceuticals Holdings, Inc. total debt
- Corbus Pharmaceuticals Holdings, Inc. cash on hand
- Corbus Pharmaceuticals Holdings, Inc. return on equity (ROE)
- Corbus Pharmaceuticals Holdings, Inc. return on invested capital (ROIC)
Corbus Pharmaceuticals Holdings, Inc. (CRBP) overview: price, valuation and scorecard
Corbus Pharmaceuticals Holdings, Inc. total assets: questions and answers
How large are Corbus Pharmaceuticals Holdings, Inc.'s total assets?
Corbus Pharmaceuticals Holdings, Inc. (CRBP) had total assets of $168.20M at the end of fiscal 2025 (December 31, 2025). That is 7.9% higher than the $155.88M of fiscal 2024.
What is the growth rate of Corbus Pharmaceuticals Holdings, Inc.'s total assets?
Over the five fiscal years to 2025 total assets grew at a compound 10.5% a year; over ten years the rate was 29.3% a year.
What are the highest and lowest total assets figures on record for Corbus Pharmaceuticals Holdings, Inc.?
Across the 13 fiscal years on record (2013–2025), the highest was $168.20M in fiscal 2025 and the lowest $305.52K in fiscal 2013.
How is Corbus Pharmaceuticals Holdings, Inc.'s total assets calculated?
Total assets is everything on the balance sheet at the fiscal year-end — cash, receivables, inventory, property, goodwill and the rest. For Corbus Pharmaceuticals Holdings, Inc. it is on record here for 13 fiscal years, 2013 to 2025.
Fiscal years are named for the calendar year they end in.
Learn: total assets
All stocks guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- Analyst price targets and ratings: what they mean
An analyst price target is a research analyst's estimate of where a share price will be at a set horizon, such as twelve months; a rating such as buy or hold is that analyst's recommendation. A consensus is an average or median of the targets a data provider has collected. Studies have found targets on average well above later prices.
Cite this page
Funkfolio, “Corbus Pharmaceuticals Holdings, Inc. (CRBP) total assets”, data as of 18 November 2026. https://funkfolio.com/stock/CRBP/total-assets
Underlying data: the company's filings with the SEC and Yahoo Finance.